1. Home
  2. RNXT vs GROV Comparison

RNXT vs GROV Comparison

Compare RNXT & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • GROV
  • Stock Information
  • Founded
  • RNXT 2012
  • GROV 2016
  • Country
  • RNXT United States
  • GROV United States
  • Employees
  • RNXT N/A
  • GROV N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • GROV Package Goods/Cosmetics
  • Sector
  • RNXT Health Care
  • GROV Consumer Discretionary
  • Exchange
  • RNXT Nasdaq
  • GROV Nasdaq
  • Market Cap
  • RNXT 44.6M
  • GROV 53.5M
  • IPO Year
  • RNXT 2021
  • GROV N/A
  • Fundamental
  • Price
  • RNXT $1.25
  • GROV $1.54
  • Analyst Decision
  • RNXT Strong Buy
  • GROV Buy
  • Analyst Count
  • RNXT 2
  • GROV 2
  • Target Price
  • RNXT $7.50
  • GROV $1.35
  • AVG Volume (30 Days)
  • RNXT 339.0K
  • GROV 89.6K
  • Earning Date
  • RNXT 08-14-2025
  • GROV 08-07-2025
  • Dividend Yield
  • RNXT N/A
  • GROV N/A
  • EPS Growth
  • RNXT N/A
  • GROV N/A
  • EPS
  • RNXT N/A
  • GROV N/A
  • Revenue
  • RNXT $662,000.00
  • GROV $185,354,000.00
  • Revenue This Year
  • RNXT $2,988.37
  • GROV N/A
  • Revenue Next Year
  • RNXT $300.60
  • GROV $11.10
  • P/E Ratio
  • RNXT N/A
  • GROV N/A
  • Revenue Growth
  • RNXT N/A
  • GROV N/A
  • 52 Week Low
  • RNXT $0.75
  • GROV $1.02
  • 52 Week High
  • RNXT $1.69
  • GROV $1.95
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 62.94
  • GROV 58.39
  • Support Level
  • RNXT $0.90
  • GROV $1.50
  • Resistance Level
  • RNXT $0.95
  • GROV $1.59
  • Average True Range (ATR)
  • RNXT 0.08
  • GROV 0.07
  • MACD
  • RNXT 0.03
  • GROV 0.00
  • Stochastic Oscillator
  • RNXT 86.54
  • GROV 72.22

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.

Share on Social Networks: